These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 23616105

  • 1. High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.
    Mul JD, Begg DP, Barrera JG, Li B, Matter EK, D'Alessio DA, Woods SC, Seeley RJ, Sandoval DA.
    Am J Physiol Regul Integr Comp Physiol; 2013 Jul 01; 305(1):R68-77. PubMed ID: 23616105
    [Abstract] [Full Text] [Related]

  • 2. Differences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats.
    Sisley S, Smith K, Sandoval DA, Seeley RJ.
    Peptides; 2014 Aug 01; 58():1-6. PubMed ID: 24879927
    [Abstract] [Full Text] [Related]

  • 3. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
    Kanoski SE, Fortin SM, Arnold M, Grill HJ, Hayes MR.
    Endocrinology; 2011 Aug 01; 152(8):3103-12. PubMed ID: 21693680
    [Abstract] [Full Text] [Related]

  • 4. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.
    Williams DL, Hyvarinen N, Lilly N, Kay K, Dossat A, Parise E, Torregrossa AM.
    Physiol Behav; 2011 Jul 06; 103(5):557-64. PubMed ID: 21515295
    [Abstract] [Full Text] [Related]

  • 5. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
    Kanoski SE, Rupprecht LE, Fortin SM, De Jonghe BC, Hayes MR.
    Neuropharmacology; 2012 Apr 06; 62(5-6):1916-27. PubMed ID: 22227019
    [Abstract] [Full Text] [Related]

  • 6. Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake.
    McKay NJ, Kanoski SE, Hayes MR, Daniels D.
    Am J Physiol Regul Integr Comp Physiol; 2011 Dec 06; 301(6):R1755-64. PubMed ID: 21975647
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
    Hayes MR, Kanoski SE, Alhadeff AL, Grill HJ.
    Obesity (Silver Spring); 2011 Jul 06; 19(7):1342-9. PubMed ID: 21415845
    [Abstract] [Full Text] [Related]

  • 8. The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice.
    Burmeister MA, Ayala JE, Smouse H, Landivar-Rocha A, Brown JD, Drucker DJ, Stoffers DA, Sandoval DA, Seeley RJ, Ayala JE.
    Diabetes; 2017 Feb 06; 66(2):372-384. PubMed ID: 27908915
    [Abstract] [Full Text] [Related]

  • 9. Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist exendin-4.
    Duca FA, Sakar Y, Covasa M.
    Diabetes; 2013 Jul 06; 62(7):2410-5. PubMed ID: 23423571
    [Abstract] [Full Text] [Related]

  • 10. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
    Barrera JG, D'Alessio DA, Drucker DJ, Woods SC, Seeley RJ.
    Diabetes; 2009 Dec 06; 58(12):2820-7. PubMed ID: 19741167
    [Abstract] [Full Text] [Related]

  • 11. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
    Tatarkiewicz K, Sablan EJ, Polizzi CJ, Villescaz C, Parkes DG.
    Am J Physiol Regul Integr Comp Physiol; 2014 Apr 01; 306(7):R490-8. PubMed ID: 24477544
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The glucagon-like peptide-1 receptor in the ventromedial hypothalamus reduces short-term food intake in male mice by regulating nutrient sensor activity.
    Burmeister MA, Brown JD, Ayala JE, Stoffers DA, Sandoval DA, Seeley RJ, Ayala JE.
    Am J Physiol Endocrinol Metab; 2017 Dec 01; 313(6):E651-E662. PubMed ID: 28811293
    [Abstract] [Full Text] [Related]

  • 14. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
    Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP.
    J Neurosci; 2012 Apr 04; 32(14):4812-20. PubMed ID: 22492036
    [Abstract] [Full Text] [Related]

  • 15. Role of lateral septum glucagon-like peptide 1 receptors in food intake.
    Terrill SJ, Jackson CM, Greene HE, Lilly N, Maske CB, Vallejo S, Williams DL.
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul 01; 311(1):R124-32. PubMed ID: 27194565
    [Abstract] [Full Text] [Related]

  • 16. Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner.
    Zhao S, Kanoski SE, Yan J, Grill HJ, Hayes MR.
    Int J Obes (Lond); 2012 Dec 01; 36(12):1522-8. PubMed ID: 22249232
    [Abstract] [Full Text] [Related]

  • 17. Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates.
    Elvert R, Herling AW, Bossart M, Weiss T, Zhang B, Wenski P, Wandschneider J, Kleutsch S, Butty U, Kannt A, Wagner M, Haack T, Evers A, Dudda A, Lorenz M, Keil S, Larsen PJ.
    Diabetes Obes Metab; 2018 Aug 01; 20(8):1836-1851. PubMed ID: 29938884
    [Abstract] [Full Text] [Related]

  • 18. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
    Baggio LL, Huang Q, Cao X, Drucker DJ.
    Gastroenterology; 2008 Apr 01; 134(4):1137-47. PubMed ID: 18313669
    [Abstract] [Full Text] [Related]

  • 19. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
    Vilsbøll T, Christensen M, Junker AE, Knop FK, Gluud LL.
    BMJ; 2012 Jan 10; 344():d7771. PubMed ID: 22236411
    [Abstract] [Full Text] [Related]

  • 20. Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight.
    Anderberg RH, Richard JE, Eerola K, López-Ferreras L, Banke E, Hansson C, Nissbrandt H, Berqquist F, Gribble FM, Reimann F, Wernstedt Asterholm I, Lamy CM, Skibicka KP.
    Diabetes; 2017 Apr 10; 66(4):1062-1073. PubMed ID: 28057699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.